Beckpharma acquires first products from Cuban biotech institute
The first product is Surfacen(TM), a natural surfactant product which can be used for the 2 million premature babies around the World who are born without sufficient quantities of their own normal surfactant that is required to help inflate their lungs in order to take their first breath of life. Supplementing the levels of surfactant in the lungs of premature babies is now a common procedure however there can be problems with the existing products which Surfacen(TM) can overcome.
The second product is NewVagin(TM), a diagnostic for identifying the main causative organisms of vaginitis, a major cause of feminine healthcare problems. NewVagin(TM) can identify a range of common pathogens in a single test, which can take place in the doctor's office rather than waiting for samples to be tested in a hospital pathology laboratory. As a result of this early diagnosis, specific and appropriate therapy can be commenced sooner with considerable benefit to the patient.
This is an important milestone for Beckpharma, as it executes its strategy of acquiring established value-added products for commercialisation in Europe. Beckpharma is now preparing regulatory dossiers for each product for submission early in 2006. Since these products are already used widely in Cuba and marketed across Latin America, the Directors believe that Beckpharma should be able to generate revenues within the next 18 to 24 months from these two products and three further high value products that are in the final stages of negotiation.
Other news from the department research and development
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.
Topic world biopharmaceutical manufacturing
Biopharmaceutical production plays a crucial role in the development and manufacture of biologics, which are essential for the treatment of various serious diseases. Various key technologies and processes of the modern biopharmaceutical industry are used, such as cell cultures, fermentation processes and the purification of biological substances, which are necessary for the production of vaccines, monoclonal antibodies and other biological drugs.